Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
暂无分享,去创建一个
[1] P. Morales,et al. Structural Insights into CB1 Receptor Biased Signaling , 2019, International journal of molecular sciences.
[2] D. Lodge,et al. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat , 2019, Schizophrenia Research.
[3] Ron O. Dror,et al. Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex , 2019, Cell.
[4] Anjali D. Ganjiwale,et al. In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor. , 2017, Journal of molecular graphics & modelling.
[5] Shan Jiang,et al. Crystal structures of agonist-bound human cannabinoid receptor CB1 , 2017, Nature.
[6] V. Di Marzo,et al. Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) , 2017, Pharmacological research.
[7] Mostafa H. Ahmed,et al. CRIP1a inhibits endocytosis of G‐protein coupled receptors activated by endocannabinoids and glutamate by a common molecular mechanism , 2017, Journal of neurochemistry.
[8] C. Bass,et al. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites , 2017, Molecular Pharmacology.
[9] Jie Yin,et al. High-resolution crystal structure of the human CB1 cannabinoid receptor , 2016, Nature.
[10] C. Bass,et al. Cannabinoid receptor interacting protein suppresses agonist‐driven CB1 receptor internalization and regulates receptor replenishment in an agonist‐biased manner , 2016, Journal of neurochemistry.
[11] R. Stevens,et al. Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.
[12] V. Di Marzo,et al. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. , 2016, Physiological reviews.
[13] S. Leone‐Kabler,et al. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function , 2016, Journal of basic and clinical physiology and pharmacology.
[14] H. Luhmann,et al. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus , 2015, Brain Structure and Function.
[15] R. Gizatullin,et al. The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway , 2015, Neuroscience.
[16] Jordan O. Cox,et al. Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation , 2015, Molecular Pharmacology.
[17] C. Bass,et al. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells. , 2015, Cellular signalling.
[18] K. Mackie,et al. Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice , 2014, The Journal of Neuroscience.
[19] Mostafa H. Ahmed,et al. Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches. , 2014, Bioorganic & medicinal chemistry letters.
[20] L. Hunyady,et al. Differential beta-arrestin2 requirements for constitutive and agonist-induced internalization of the CB cannabinoid receptor. , 2013 .
[21] L. Hunyady,et al. Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor , 2013, Molecular and Cellular Endocrinology.
[22] C. Bass,et al. Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems , 2013, Journal of neurochemistry.
[23] Peter T. Nguyen,et al. β-Arrestin2 Regulates Cannabinoid CB1 Receptor Signaling and Adaptation in a Central Nervous System Region–Dependent Manner , 2012, Biological Psychiatry.
[24] D. Centonze,et al. Effects of palmitoylation of Cys415 in helix 8 of the CB1 cannabinoid receptor on membrane localization and signalling , 2012, British journal of pharmacology.
[25] George D. Dalton,et al. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells , 2012, British journal of pharmacology.
[26] L. Kanit,et al. Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures , 2012, Epilepsy Research.
[27] Ryan T. Strachan,et al. Distinct Phosphorylation Sites on the β2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of β-Arrestin , 2011, Science Signaling.
[28] A. Makriyannis,et al. Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2. , 2011, Biochemistry.
[29] D. Selley,et al. Cannabinoid CB1 receptor‐interacting proteins: novel targets for central nervous system drug discovery? , 2010, British journal of pharmacology.
[30] A. Howlett,et al. CB(1) cannabinoid receptors and their associated proteins. , 2010, Current medicinal chemistry.
[31] Achani K. Yatawara,et al. Structural analysis of the human cannabinoid receptor one carboxyl‐terminus identifies two amphipathic helices , 2009, Biopolymers.
[32] C. Breivogel,et al. Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice , 2008, Behavioural pharmacology.
[33] T. Daigle,et al. Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation‐dependent mechanism , 2008, Journal of neurochemistry.
[34] Masahiko Watanabe,et al. Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.
[35] T. Daigle,et al. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling , 2008, Neuropharmacology.
[36] M. Elphick,et al. CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a , 2007, Molecular Pharmacology.
[37] R. Mercier,et al. Interaction of a fragment of the cannabinoid CB1 receptor C‐terminus with arrestin‐2 , 2007, FEBS letters.
[38] Beat Lutz,et al. The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.
[39] T. Rubino,et al. Changes in the expression of G protein-coupled receptor kinases and β-arrestins in mouse brain during cannabinoid tolerance , 2006, Molecular Neurobiology.
[40] A. Howlett,et al. Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions , 2005, Molecular Pharmacology.
[41] J. Shim,et al. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. , 2002, Chemistry and physics of lipids.
[42] M. Herkenham,et al. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.
[43] M. Kouznetsova,et al. Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. , 2002, Molecular pharmacology.
[44] J. Nie,et al. Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration , 2001, The Journal of Neuroscience.
[45] J. Nie,et al. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling , 2001, Neuroscience.
[46] A. Howlett,et al. CB1 receptor–G protein association , 2001 .
[47] K. Mackie,et al. Internalization and Recycling of the CB1 Cannabinoid Receptor , 1999, Journal of neurochemistry.
[48] K. Mackie,et al. Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization , 1999, The Journal of Neuroscience.
[49] S. M. Cowsik,et al. Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis. , 1999, Biochemistry.
[50] A. Howlett,et al. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. , 1998, Cellular signalling.
[51] E. Dainese,et al. Role of palmitoylation of cysteine 415 in functional coupling CB1 receptor to Gαi2 protein , 2018, Biotechnology and applied biochemistry.
[52] H. Bradshaw,et al. Endocannabinoid Analytical Methodologies: Techniques That Drive Discoveries That Drive Techniques. , 2017, Advances in pharmacology.
[53] A. Howlett,et al. CB1 and CB2 Receptor Pharmacology. , 2017, Advances in pharmacology.
[54] M. Elphick,et al. CB 1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1 a , 2007 .
[55] T. Rubino,et al. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. , 2006, Molecular neurobiology.
[56] A. Howlett,et al. CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. , 2001, European journal of biochemistry.
[57] A. Howlett,et al. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. , 2000, Molecular pharmacology.
[58] A. Howlett,et al. Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. , 1993, Molecular pharmacology.